Soufflé Therapeutics

Therapeutic Devices · Watertown, MA · Founded 2021 · Privately Held (backing)

Developer of a targeted gene therapy intended to treat autoimmune diseases and cardiac diseases. Soufflé Therapeutics is based in Watertown, MA and was founded in 2021. It was valued at $345 million at its early-stage round in Oct 2025, the last priced event on record. It has raised $241 million across 1 recorded round; the latest was a $200 million Series A in Oct 2025.

PMV mark · valuation
$344.5M
Oct 2026
Priced at
its early-stage round
Oct 2025
Total raised
$240.6M
Last round
Early Stage VC (Series A)
Oct 2025
How much has Soufflé Therapeutics raised?
$240.6Macross 1 recorded rounds · Oct 2025 – Oct 2025

Most recently, Soufflé Therapeutics raised $200.0M in its Early Stage VC (Series A) (Oct 2025).

Free account
More of Soufflé Therapeutics with a free account
  • ·The complete investor list: 13 names
  • ·Watch Soufflé Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Soufflé Therapeutics round by round

1 rounds
Oct 2025Early Stage VC (Series A)$200.0M▮
+ 1 more investors · free account

How much has Soufflé Therapeutics raised?

Soufflé Therapeutics has raised $241 million across 1 recorded round since 2025. The largest was a $200 million Series A in Oct 2025.

Soufflé Therapeutics investors

13 investors are on record for Soufflé Therapeutics, including Bessemer Venture Partners, Temasek Holdings, Breyer Capital and ARCH Venture Partners. By type, the record holds 4 venture capital firms, 1 private equity firm and 1 growth equity firm. The Series A in Oct 2025 drew 9 investors.

For fundraisers
Raising for a company like Soufflé Therapeutics?

13 investors have backed Soufflé Therapeutics — start your target list with the firms already writing checks in therapeutic devices.

See all 13 investors →

Frequently asked about Soufflé Therapeutics

How much has Soufflé Therapeutics raised?
Soufflé Therapeutics has raised $240.6M in total across 1 recorded funding rounds.
When was Soufflé Therapeutics's last funding round?
Soufflé Therapeutics's most recent recorded round was Early Stage VC (Series A) in Oct 2025, raising $200.0M.